Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responses

被引:198
作者
Mathur, RK [1 ]
Awasthi, A [1 ]
Wadhone, P [1 ]
Ramanamurthy, B [1 ]
Saha, B [1 ]
机构
[1] Natl Ctr Cell Sci, Pune 411007, Maharashtra, India
关键词
D O I
10.1038/nm1045
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Macrophages play host to Leishmania major, a parasite that causes leishmaniasis in 500,000 people annually. Macrophage-expressed CD40, a costimulatory molecule 1, induces interleukin-12 (IL-12)-dependent and interferon-gamma (IFN-gamma)-dependent host-protective immune responses to Leishmania and other intracellular pathogens(2-6). Paradoxically, IL-10, another CD40-induced cytokine in macrophages(7), promotes Leishmania infection(8). How CD40 signaling regulates the secretion of these two counteractive cytokines remains unknown. Here we show that weak CD40 signals induce extracellular stress-related kinase-1/2 (ERK-1/ 2)-dependent IL-10 expression, whereas stronger signals induce p38 mitogen-activated protein kinase (p38MAPK) dependent IL-12 production. p38MAPK and ERK-1/ 2 therefore have counter-regulatory actions. Leishmania skews CD40 signaling toward ERK-1/ 2, inducing IL-10, which inhibits activation of CD40-induced p38MAPK and expression of inducible nitric oxide synthase-2 (iNOS-2) and IL-12. ERK-1/ 2 inhibition or IL-10 neutralization restores CD40-induced p38MAPK activation and parasite killing in macrophages and the BALB/c mouse, a susceptible host. These data uncover a new immune evasion strategy, whereby Leishmania differentially modulates CD40-engaged, reciprocally functioning signaling modules, and provide a new conceptual framework for immune homeostasis.
引用
收藏
页码:540 / 544
页数:5
相关论文
共 33 条
[1]   CD40 signaling is impaired in L. major-infected macrophages and is rescued by a p38MAPK activator establishing a host-protective memory T cell response [J].
Awasthi, A ;
Mathur, R ;
Khan, A ;
Joshi, BN ;
Jain, N ;
Sawant, S ;
Boppana, R ;
Mitra, D ;
Saha, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (08) :1037-1043
[2]  
Belkaid Y, 1998, EUR J IMMUNOL, V28, P1389, DOI 10.1002/(SICI)1521-4141(199804)28:04&lt
[3]  
1389::AID-IMMU1389&gt
[4]  
3.0.CO
[5]  
2-1
[6]   The role of interleukin (IL)-10 in the persistence of Leishmania major in the skin after healing and the therapeutic potential of anti-IL-10 receptor antibody for sterile cure [J].
Belkaid, Y ;
Hoffmann, KF ;
Mendez, S ;
Kamhawi, S ;
Udey, MC ;
Wynn, TA ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (10) :1497-1506
[7]   PARALLEL SIGNAL-PROCESSING AMONG MAMMALIAN MAPKS [J].
CANO, E ;
MAHADEVAN, LC .
TRENDS IN BIOCHEMICAL SCIENCES, 1995, 20 (03) :117-122
[8]   Leishmania promastigotes selectively inhibit interleukin 12 induction in bone marrow-derived macrophages from susceptible and resistant mice [J].
Carrera, L ;
Gazzinelli, RT ;
Badolato, R ;
Hieny, S ;
Muller, W ;
Kuhn, R ;
Sacks, DL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (02) :515-526
[9]   MAP kinase-mediated phosphoacetylation of histone H3 and inducible gene regulation [J].
Clayton, AL ;
Mahadevan, LC .
FEBS LETTERS, 2003, 546 (01) :51-58
[10]   T cell proliferation in response to interleukins 2 and 7 requires p38MAP kinase activation [J].
Crawley, JB ;
Rawlinson, L ;
Lali, FV ;
Page, TH ;
Saklatvala, J ;
Foxwell, BMJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (23) :15023-15027